EIDX - Eidos Therapeutics Inc
Previous close
122.21
0 0%
Share volume: 335,508
Last Updated: Mon 25 Jan 2021 06:00:00 AM CET
Pharmaceutical Preparation Manufacturing :
-2.88%
PREVIOUS CLOSE
CHG
CHG%
$122.21
0.00
0.00%
Summary score
22%
Profitability
25%
Dept financing
6%
Liquidity
50%
Performance
15%
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Long-term ratios 30-Sep-2016 - 30-Sep-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-16.56%
Return on assets
-10.5%
Return on sales
-11564.27%
Return on invested capital
374.57%
Total debt ratio
12.81%
Debt ratio change over timeo
-0.98%
Current Ratio
19.51%
Quick Ratio
0%
Cash Position Ratio
19.12%
Short-term ratios 30-Sep-2019 - 30-Sep-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-17%
Return on assets
-13.45%
Return on sales
-23151.97%
Return on invested capital
558.36%
Total debt ratio
18.99%
Debt ratio change over timeo
-0.98%
Current Ratio
14.62%
Quick Ratio
0%
Cash Position Ratio
14.24%
Last quarter ratios 30-Sep-2020
The data are presented for the financials results of the last quarter.
Return on equity
-24.56%
Return on assets
-18.22%
Return on sales
-23151.97%
Return on invested capital
500.93%
Total debt ratio
23.86%
Debt ratio change over time
-0.94%
Current Ratio
11.1%
Quick Ratio
0%
Cash Position Ratio
10.66%
Performance ratios (change over 4 years) 30-Sep-2016 - 30-Sep-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-101.79%
Return on assets
-101.6%
Return on sales
-3110.34%
Return on invested capital
-68.73%
Total debt ratio
-98.35%
Debt ratio change over time
-0.98%
Current Ratio
4.41%
Quick Ratio
0%
Cash Position Ratio
4.31%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | EIDX | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | -16.56% | 0% | 0% | 26.83% |
| Return on assets | -10.5% | 0% | 0% | -10.24% |
| Return on sales | -11564.27% | 0% | 0% | -1670.47% |
| Return on invested capital | 374.57% | 0% | 0% | 57.71% |
| Profitability | 25% | 0% | 50% | 29% |
| Total debt ratio | 12.81% | 0% | 0% | 168.24% |
| Debt ratio change over time | -0.98% | 0% | 0% | 17.84% |
| Dept financing | 2% | 0% | 0% | 50% |
| Current Ratio | 14.62% | 0% | 0% | 8.32% |
| Quick Ratio | 0% | 0% | 0% | 8.32% |
| Cash Position Ratio | 14.24% | 0% | 0% | 7.97% |
| Liquididy | 50% | 0% | 0% | 37% |
| Short-term ratios | EIDX | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | -17% | 0% | 0% | -39.65% |
| Return on assets | -13.45% | 0% | 0% | -13.45% |
| Return on sales | -23151.97% | 0% | 0% | -4352.39% |
| Return on invested capital | 558.36% | 0% | 0% | 120.66% |
| Profitability | 25% | 0% | 75% | 5% |
| Total debt ratio | 18.99% | 0% | 0% | 65.53% |
| Debt ratio change over time | -0.98% | 0% | 0% | 0.08% |
| Dept financing | 7% | 0% | 0% | 50% |
| Current Ratio | 14.62% | 0% | 0% | 8.32% |
| Quick Ratio | 0% | 0% | 0% | 8.32% |
| Cash Position Ratio | 14.24% | 0% | 0% | 7.97% |
| Liquididy | 50% | 0% | 0% | 53% |